vs
DYNEX CAPITAL INC（DX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是DYNEX CAPITAL INC的1.6倍（$69.8M vs $43.5M），DYNEX CAPITAL INC同比增速更快（531.3% vs 21.2%），过去两年DYNEX CAPITAL INC的营收复合增速更高（75.8% vs 53.7%）
Dynex Capital Inc是一家总部位于美国的上市房地产投资信托公司，专注于投资和管理抵押贷款支持证券、住宅及商业抵押贷款等各类抵押相关资产组合，通过稳健运营为股东创造稳定分红和长期资本增值。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DX vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$43.5M
营收增速更快
DX
高出510.1%
21.2%
两年增速更快
DX
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.5M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 531.3% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $1.59 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXRIGL
| Q4 25 | $43.5M | $69.8M | ||
| Q3 25 | $30.6M | $69.5M | ||
| Q2 25 | $23.1M | $101.7M | ||
| Q1 25 | $17.1M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | — | $55.3M | ||
| Q2 24 | — | $36.8M | ||
| Q1 24 | $-3.2M | $29.5M |
净利润DXRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $150.4M | $27.9M | ||
| Q2 25 | $-13.6M | $59.6M | ||
| Q1 25 | $-3.1M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | $40.1M | $-8.2M |
毛利率DXRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率DXRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -23.6% |
净利率DXRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 491.3% | 40.2% | ||
| Q2 25 | -58.8% | 58.6% | ||
| Q1 25 | -18.0% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | -1256.8% | -27.9% |
每股收益（稀释后）DXRIGL
| Q4 25 | $1.59 | $14.11 | ||
| Q3 25 | $1.08 | $1.46 | ||
| Q2 25 | $-0.14 | $3.28 | ||
| Q1 25 | $-0.06 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | $0.64 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $531.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $2.5B | $391.5M |
| 总资产 | $17.3B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DXRIGL
| Q4 25 | $531.0M | $155.0M | ||
| Q3 25 | $491.0M | $137.1M | ||
| Q2 25 | $387.5M | $108.4M | ||
| Q1 25 | $327.4M | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | $295.7M | $49.5M |
总债务DXRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益DXRIGL
| Q4 25 | $2.5B | $391.5M | ||
| Q3 25 | $2.0B | $117.6M | ||
| Q2 25 | $1.6B | $81.9M | ||
| Q1 25 | $1.4B | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-29.9M | ||
| Q1 24 | $958.5M | $-31.7M |
总资产DXRIGL
| Q4 25 | $17.3B | $513.6M | ||
| Q3 25 | $14.2B | $242.5M | ||
| Q2 25 | $11.3B | $206.7M | ||
| Q1 25 | $9.0B | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | — | $139.4M | ||
| Q2 24 | — | $128.4M | ||
| Q1 24 | $6.3B | $126.5M |
负债/权益比DXRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $120.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DXRIGL
| Q4 25 | $120.8M | $22.0M | ||
| Q3 25 | $68.3M | $24.0M | ||
| Q2 25 | $31.9M | $30.5M | ||
| Q1 25 | $6.4M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | — | $21.7M | ||
| Q2 24 | — | $302.0K | ||
| Q1 24 | $-17.1M | $-5.0M |
现金转化率DXRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 0.45× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
